170 related articles for article (PubMed ID: 38103364)
1. From carcinogenesis to therapeutic avenues: lncRNAs and mTOR crosstalk in lung cancer.
Hussain MS; Altamimi ASA; Afzal M; Almalki WH; Kazmi I; Alzarea SI; Saleem S; Prasher P; Oliver B; Singh SK; MacLoughlin R; Dua K; Gupta G
Pathol Res Pract; 2024 Jan; 253():155015. PubMed ID: 38103364
[TBL] [Abstract][Full Text] [Related]
2. Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review.
Moslehian MS; Shabkhizan R; Asadi MR; Bazmani A; Mahdipour M; Haiaty S; Rahbarghazi R; Sakhinia E
BMC Cancer; 2023 Jun; 23(1):512. PubMed ID: 37280524
[TBL] [Abstract][Full Text] [Related]
3. Exploring the lncRNA-VEGF axis: Implications for cancer detection and therapy.
Alharthi NS; Al-Zahrani MH; Hazazi A; Alhuthali HM; Gharib AF; Alzahrani S; Altalhi W; Almalki WH; Khan FR
Pathol Res Pract; 2024 Jan; 253():154998. PubMed ID: 38056133
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
[TBL] [Abstract][Full Text] [Related]
5. The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression.
Tu C; Yang K; Wan L; He J; Qi L; Wang W; Lu Q; Li Z
Cell Prolif; 2020 Sep; 53(9):e12887. PubMed ID: 32779318
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression.
Lu QC; Rui ZH; Guo ZL; Xie W; Shan S; Ren T
J Cell Mol Med; 2018 Mar; 22(3):1527-1537. PubMed ID: 29266795
[TBL] [Abstract][Full Text] [Related]
7. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer.
Almalki WH
Pathol Res Pract; 2023 Nov; 251():154852. PubMed ID: 37837857
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer.
Thapa R; Afzal O; Gupta G; Bhat AA; Almalki WH; Alzarea SI; Kazmi I; Altamimi ASA; Subramaniyan V; Thangavelu L; Singh SK; Dua K
Pathol Res Pract; 2023 Sep; 249():154736. PubMed ID: 37579591
[TBL] [Abstract][Full Text] [Related]
9. SP1-induced overexpression of LINC00520 facilitates non-small cell lung cancer progression through miR-577/CCNE2 pathway and predicts poor prognosis.
Wang JF; Xi ZN; Su HJ; Bao Z; Qiao YH
Hum Cell; 2021 May; 34(3):952-964. PubMed ID: 33728585
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis.
Najafi S; Khatami SH; Khorsand M; Jamali Z; Shabaninejad Z; Moazamfard M; Majidpoor J; Aghaei Zarch SM; Movahedpour A
Exp Cell Res; 2022 Sep; 418(2):113294. PubMed ID: 35870535
[TBL] [Abstract][Full Text] [Related]
11. A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response.
Sharma U; Murmu M; Barwal TS; Tuli HS; Jain M; Prakash H; Kaceli T; Jain A; Bishayee A
Curr Oncol; 2022 Mar; 29(4):2326-2349. PubMed ID: 35448163
[TBL] [Abstract][Full Text] [Related]
12. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.
Fang C; Wang L; Gong C; Wu W; Yao C; Zhu S
J Cell Mol Med; 2020 Mar; 24(6):3282-3291. PubMed ID: 32048814
[TBL] [Abstract][Full Text] [Related]
14. Roles of long-non-coding RNAs in cancer therapy through the PI3K/Akt signalling pathway.
Lee KT; Gopalan V; Lam AK
Histol Histopathol; 2019 Jun; 34(6):593-609. PubMed ID: 30620381
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs in the mTOR signaling network: biomarkers and therapeutic targets.
Huang T; Wang M; Huang B; Chang A; Liu F; Zhang Y; Jiang B
Apoptosis; 2018 Jun; 23(5-6):255-264. PubMed ID: 29556906
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
[TBL] [Abstract][Full Text] [Related]
17. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.
Yang G; Shen T; Yi X; Zhang Z; Tang C; Wang L; Zhou Y; Zhou W
J Cell Mol Med; 2018 Apr; 22(4):2062-2070. PubMed ID: 29392884
[TBL] [Abstract][Full Text] [Related]
19. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
Yang Y; Dai W; Sun Y; Zhao Z
Oncol Rep; 2019 Apr; 41(4):2311-2320. PubMed ID: 30720129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
